Supernus Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products for central nervous system (CNS) diseases. With over 30 years of experience, it engages in research and development to create novel therapeutics aimed at improving patient health outcomes. The company operates in various therapeutic categories, offering a portfolio of products designed to address the needs of patients with CNS conditions.
- Website
- www.supernus.com
- Issuer profile
- All listings